Sarcrassin E

Details

Top
Internal ID e13957e7-5ebf-407f-92ba-cd63d4aea815
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene lactones
IUPAC Name methyl (1S,5E,7E)-1-methyl-2,16-dioxo-8-propan-2-yl-15-oxabicyclo[9.3.2]hexadeca-5,7,11-triene-5-carboxylate
SMILES (Canonical) CC(C)C1=CC=C(CCC(=O)C2(CCC=C(CC1)C(=O)O2)C)C(=O)OC
SMILES (Isomeric) CC(C)/C/1=C/C=C(\CCC(=O)[C@@]2(CCC=C(CC1)C(=O)O2)C)/C(=O)OC
InChI InChI=1S/C21H28O5/c1-14(2)15-7-9-16-6-5-13-21(3,26-20(16)24)18(22)12-11-17(10-8-15)19(23)25-4/h6,8,10,14H,5,7,9,11-13H2,1-4H3/b15-8+,17-10+/t21-/m0/s1
InChI Key SSRWHVBVQPAITB-WYLCAHHTSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C21H28O5
Molecular Weight 360.40 g/mol
Exact Mass 360.19367399 g/mol
Topological Polar Surface Area (TPSA) 69.70 Ų
XlogP 3.50
Atomic LogP (AlogP) 3.83
H-Bond Acceptor 5
H-Bond Donor 0
Rotatable Bonds 2

Synonyms

Top
KETOEMBLIDE
CHEMBL470654
BDBM50438610
81499-21-0

2D Structure

Top
2D Structure of Sarcrassin E

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9839 98.39%
Caco-2 + 0.7785 77.85%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability + 0.5286 52.86%
Subcellular localzation Mitochondria 0.7258 72.58%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9004 90.04%
OATP1B3 inhibitior + 0.9494 94.94%
MATE1 inhibitior - 0.7800 78.00%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior + 0.7774 77.74%
P-glycoprotein inhibitior - 0.5978 59.78%
P-glycoprotein substrate - 0.8196 81.96%
CYP3A4 substrate + 0.6389 63.89%
CYP2C9 substrate - 0.8092 80.92%
CYP2D6 substrate - 0.9043 90.43%
CYP3A4 inhibition - 0.7043 70.43%
CYP2C9 inhibition - 0.7760 77.60%
CYP2C19 inhibition - 0.7642 76.42%
CYP2D6 inhibition - 0.9406 94.06%
CYP1A2 inhibition - 0.5999 59.99%
CYP2C8 inhibition + 0.4561 45.61%
CYP inhibitory promiscuity - 0.9642 96.42%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7743 77.43%
Carcinogenicity (trinary) Non-required 0.6455 64.55%
Eye corrosion - 0.9815 98.15%
Eye irritation - 0.8743 87.43%
Skin irritation - 0.6185 61.85%
Skin corrosion - 0.9543 95.43%
Ames mutagenesis - 0.5900 59.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7900 79.00%
Micronuclear - 0.6400 64.00%
Hepatotoxicity + 0.5140 51.40%
skin sensitisation - 0.6971 69.71%
Respiratory toxicity + 0.6111 61.11%
Reproductive toxicity + 0.6000 60.00%
Mitochondrial toxicity + 0.6500 65.00%
Nephrotoxicity + 0.7845 78.45%
Acute Oral Toxicity (c) III 0.5394 53.94%
Estrogen receptor binding - 0.5890 58.90%
Androgen receptor binding - 0.5191 51.91%
Thyroid receptor binding - 0.5771 57.71%
Glucocorticoid receptor binding + 0.6132 61.32%
Aromatase binding - 0.5949 59.49%
PPAR gamma - 0.5422 54.22%
Honey bee toxicity - 0.8397 83.97%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.6700 67.00%
Fish aquatic toxicity + 0.9782 97.82%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 6330 nM
IC50
PMID: 23859780

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.46% 91.11%
CHEMBL4040 P28482 MAP kinase ERK2 98.02% 83.82%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.78% 96.09%
CHEMBL2581 P07339 Cathepsin D 93.61% 98.95%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 89.97% 99.23%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 86.49% 91.07%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 86.06% 94.45%
CHEMBL4208 P20618 Proteasome component C5 85.74% 90.00%
CHEMBL3401 O75469 Pregnane X receptor 85.72% 94.73%
CHEMBL5028 O14672 ADAM10 83.68% 97.50%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 82.47% 95.56%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 81.80% 93.03%

Cross-Links

Top
PubChem 16091635
NPASS NPC221231
ChEMBL CHEMBL470654
LOTUS LTS0032123
wikiData Q105259858